Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Illness | 2 | 2024 | 6 | 1.860 |
Why?
|
| Respiration, Artificial | 2 | 2024 | 6 | 1.860 |
Why?
|
| Music Therapy | 2 | 2024 | 15 | 1.830 |
Why?
|
| Critical Care | 1 | 2024 | 12 | 0.930 |
Why?
|
| Cognition | 1 | 2024 | 174 | 0.800 |
Why?
|
| Tissue Donors | 7 | 2015 | 11 | 0.610 |
Why?
|
| Adult | 15 | 2024 | 1683 | 0.540 |
Why?
|
| Heart Transplantation | 5 | 2016 | 5 | 0.530 |
Why?
|
| Humans | 20 | 2024 | 5476 | 0.420 |
Why?
|
| Middle Aged | 13 | 2024 | 1098 | 0.410 |
Why?
|
| Wounds and Injuries | 3 | 2022 | 5 | 0.330 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 74 | 0.330 |
Why?
|
| Male | 14 | 2024 | 2765 | 0.320 |
Why?
|
| Lung Transplantation | 4 | 2012 | 5 | 0.300 |
Why?
|
| Female | 13 | 2024 | 2811 | 0.300 |
Why?
|
| Graft Survival | 3 | 2016 | 4 | 0.290 |
Why?
|
| Retrospective Studies | 9 | 2022 | 382 | 0.280 |
Why?
|
| Trauma Centers | 2 | 2021 | 2 | 0.280 |
Why?
|
| Aged | 4 | 2024 | 859 | 0.260 |
Why?
|
| Communication Barriers | 2 | 2022 | 3 | 0.250 |
Why?
|
| Intensive Care Units | 1 | 2024 | 17 | 0.230 |
Why?
|
| Delirium | 1 | 2024 | 7 | 0.230 |
Why?
|
| Qualitative Research | 1 | 2024 | 47 | 0.230 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 47 | 0.220 |
Why?
|
| Music | 1 | 2024 | 42 | 0.220 |
Why?
|
| Donor Selection | 2 | 2013 | 2 | 0.210 |
Why?
|
| Brain Death | 2 | 2012 | 2 | 0.200 |
Why?
|
| Polymorphism, Genetic | 2 | 2012 | 14 | 0.200 |
Why?
|
| Anxiety | 1 | 2024 | 173 | 0.200 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 6 | 0.190 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 18 | 0.190 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 52 | 0.190 |
Why?
|
| Drug Overdose | 1 | 2021 | 6 | 0.180 |
Why?
|
| Duodenal Ulcer | 1 | 2020 | 1 | 0.170 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2020 | 2 | 0.170 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 10 | 0.170 |
Why?
|
| Tissue and Organ Procurement | 3 | 2012 | 3 | 0.170 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 35 | 0.150 |
Why?
|
| Waiting Lists | 1 | 2016 | 2 | 0.130 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 284 | 0.130 |
Why?
|
| Heart Failure | 1 | 2016 | 32 | 0.130 |
Why?
|
| Health Care Rationing | 1 | 2015 | 1 | 0.120 |
Why?
|
| Risk Factors | 5 | 2021 | 184 | 0.120 |
Why?
|
| California | 4 | 2021 | 10 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2013 | 17 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2012 | 1 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 5 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2012 | 11 | 0.100 |
Why?
|
| Electrocardiography | 1 | 2012 | 14 | 0.100 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2012 | 1 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2012 | 11 | 0.100 |
Why?
|
| Pain Measurement | 2 | 2022 | 17 | 0.100 |
Why?
|
| Mass Screening | 1 | 2011 | 11 | 0.090 |
Why?
|
| Young Adult | 4 | 2021 | 850 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2011 | 8 | 0.090 |
Why?
|
| Time Factors | 3 | 2021 | 176 | 0.090 |
Why?
|
| Drug Prescriptions | 2 | 2021 | 26 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 52 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2011 | 52 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2016 | 131 | 0.080 |
Why?
|
| Troponin I | 1 | 2007 | 2 | 0.070 |
Why?
|
| Logistic Models | 3 | 2013 | 69 | 0.070 |
Why?
|
| San Francisco | 2 | 2021 | 5 | 0.070 |
Why?
|
| Myocardium | 1 | 2007 | 35 | 0.070 |
Why?
|
| Adolescent | 3 | 2021 | 806 | 0.070 |
Why?
|
| Transplantation, Homologous | 3 | 2012 | 7 | 0.070 |
Why?
|
| Organ Preservation | 1 | 2005 | 1 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2005 | 2 | 0.060 |
Why?
|
| Reperfusion Injury | 1 | 2005 | 4 | 0.060 |
Why?
|
| Chi-Square Distribution | 3 | 2012 | 7 | 0.060 |
Why?
|
| United States | 2 | 2016 | 521 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 1 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2013 | 19 | 0.050 |
Why?
|
| Blood Alcohol Content | 1 | 2022 | 5 | 0.050 |
Why?
|
| Pain | 1 | 2022 | 40 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2021 | 17 | 0.050 |
Why?
|
| Pain Management | 1 | 2021 | 14 | 0.050 |
Why?
|
| Genotype | 2 | 2012 | 58 | 0.050 |
Why?
|
| Acute Disease | 1 | 2021 | 9 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 97 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2013 | 49 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 32 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 23 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 320 | 0.040 |
Why?
|
| Outpatients | 1 | 2019 | 11 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 38 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2013 | 212 | 0.040 |
Why?
|
| ABO Blood-Group System | 1 | 2016 | 1 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 13 | 0.030 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 2 | 0.030 |
Why?
|
| Prognosis | 1 | 2012 | 59 | 0.030 |
Why?
|
| Sympathetic Nervous System | 1 | 2012 | 3 | 0.030 |
Why?
|
| Echocardiography | 1 | 2012 | 10 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 19 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2011 | 1 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2011 | 2 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2011 | 7 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2011 | 14 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 1 | 0.020 |
Why?
|
| Inpatients | 1 | 2011 | 31 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 72 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 119 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2011 | 132 | 0.020 |
Why?
|
| Patient Selection | 1 | 2005 | 10 | 0.020 |
Why?
|
| Lung | 1 | 2005 | 42 | 0.020 |
Why?
|
| Biomarkers | 1 | 2005 | 87 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 15 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2002 | 30 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2002 | 31 | 0.010 |
Why?
|